Pfizer has launched mid-to-late-stage trials on a new oral antiviral drug that could prevent COVID-19.
The trials will test over 26-hundred adults who are living with a symptomatic coronavirus patient.
They'll will also get a small dose of Ritonavir, an antiviral drug designed to treat HIV, along with a dose of the COVID-19 candidate drug.
One third will be given placebos.
Pfizer is also working on an oral treatment for COVID-19.
The results of that study are due later this year.
01:56
Parts of Chungcheong-do to see over 300mm of rainfall until Friday as S. Korean storm moves south
02:33
02:43
02:27
01:46
02:00
02:31
00:37
